FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

17628011000001101: Erythrolar 250mg tablets (Ennogen Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 25-Aug 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
60717601000001114 Erythrolar 250mg tablets (Ennogen Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
69113401000001110 Erythrolar 250mg tablets (Ennogen Pharma Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Erythrolar 250mg tablets (Ennogen Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Erythrolar 250mg tablets (Ennogen Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Erythrolar 250mg tablets (Ennogen Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Erythrolar 250mg tablets (Ennogen Ltd) Is a Product containing precisely erythromycin (as erythromycin stearate) 250 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Erythrolar 250mg tablets (Ennogen Ltd) Has active ingredient Erythromycin stearate false Inferred relationship Existential restriction modifier
Erythrolar 250mg tablets (Ennogen Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Erythrolar 250mg tablets (Ennogen Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Erythrolar 250mg tablets (Ennogen Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Erythrolar 250mg tablets (Ennogen Ltd) Has specific active ingredient Erythromycin stearate true Inferred relationship Existential restriction modifier
Erythrolar 250mg tablets (Ennogen Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Erythrolar 250mg tablets (Ennogen Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Erythromycin true Inferred relationship Existential restriction modifier
Erythrolar 250mg tablets (Ennogen Ltd) Has excipient Tartrazine stain false Inferred relationship Existential restriction modifier
Erythrolar 250mg tablets (Ennogen Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Erythrolar 250mg tablets (Ennogen Ltd) Is a Erythrolar true Inferred relationship Existential restriction modifier
Erythrolar 250mg tablets (Ennogen Ltd) Has basis of strength substance Erythromycin true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Erythrolar 250mg tablets (Ennogen Ltd) 100 tablet Has AMP True Erythrolar 250mg tablets (Ennogen Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start